Home |

GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter

GSK launches $2.5 billion buyback, lifts sales target after stellar fourth quarter

6 February 2025, 2:29 pm

1 min read

GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration

Reuters was nearly 5 minutes ahead of the competition when GlaxoSmithKline launched a $2.5 billion share buyback after a strong fourth quarter.

Shein poised to slash valuation to $50 billion in London IPO

Trump pauses tariffs on Mexico and Canada, but not China

Be the first to know